Corowell offers an easy, rapid & low-cost way to objectively identify suspected COVID-19 infections by testing the sense of smell.

SCAN. SCRATCH. SMELL. SELECT. PASS.

YOUR PARTNER TO SAFELY EXIT OUT OF LOCKDOWN

Current COVID-19 tests are costly, slow, infrequent and not suitable for mass testing
What are the Problems
we are addressing?
Risk of getting infected and/or infecting others
Current COVID-19 tests are costly, slow, infrequent and not suitable for mass testing
Businesses need to protect their assets from the effect of COVID-19 infections
How does Corowell meet those Challenges?
Non-invasive, rapid, low-cost, readily available and scalable corowell

Objectively
identify COVID-19
infections

Objectively identify COVID-19 infections corowell

Non-invasive, rapid,
low-cost, readily
available and scalable

High level of confidence for a COVID-19-free business environment corowell

High level of confidence
for a COVID-19-free
business environment

For anyone, anytime, anywhere.

Plane / Bus / Train
Stadium / Concert
School / University
Restaurant / Hotel
Cruise Ship
Public / Business
Previous
Next

Get your life back one ticket at a time

corowell
corowell get your life back one card at a time

Our Founders

Dr. Markus Haller
CEO

Chairman & Founder of Aureliym GmbH, Cansativa Medical Devices,
 MKG Consulting and more

Over 30 years of international experience in MedTech

75 patents filed

Developed 4 start-ups from foundation to success

Alexander Wegener
CTO

Director & Founder of Aureliym GmbH 
(Medical app & cloud systems)

Expert in Quality Management and Regulatory Affairs

Highly experienced engineer with >20 years experience in invasive and 
non-invasive medical technologies

Simon Ernst
COO & VP of Sales

Chairman & Founder of InnSecCon 
(Consulting for Security System)

Over 20 years of international experience in Technical, Sales and Management functions in Smiths Heimann GmbH and CEIA GmbH

Ready when you are

Contact